Close
Back to LOGC Stock Lookup

LogicBio Therapeutics (LOGC) – PRNewswire

Nov 14, 2022 08:00 AM LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
Oct 3, 2022 07:00 AM Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine
Sep 21, 2022 08:30 AM LogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONE
Aug 15, 2022 07:05 AM LogicBio Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
May 17, 2022 08:30 AM LogicBio® Therapeutics to Present at H.C. Wainwright Global Investment Conference
May 16, 2022 08:30 AM LogicBio Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Business Updates
May 11, 2022 08:30 AM LogicBio Therapeutics Announces Upcoming Presentations on GeneRide Development Candidate and Multiple Advancements in AAV Manufacturing Processes at ASGCT Annual Meeting
May 9, 2022 08:00 AM LogicBio Therapeutics Announces FDA Lifts Clinical Hold on SUNRISE Trial in Pediatric Patients with Methylmalonic Acidemia
Mar 23, 2022 04:30 PM LogicBio Therapeutics to Present at H.C. Wainwright Gene Therapy and Gene Editing Conference
Mar 8, 2022 04:05 PM LogicBio Therapeutics to Present at Barclays Global Healthcare Conference
Mar 4, 2022 04:05 PM LogicBio Therapeutics Reports Full Year 2021 Financial Results and Provides Business Updates
Feb 2, 2022 06:00 AM LogicBio Therapeutics Provides Update on LB-001 Clinical Development Program
Jan 4, 2022 08:00 AM LogicBio Therapeutics to Present at the H.C. Wainwright Bioconnect Conference
Dec 22, 2021 08:00 AM LogicBio Therapeutics Provides Business Updates
Nov 15, 2021 07:00 AM LogicBio Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Milestones
Nov 11, 2021 04:05 PM LogicBio Therapeutics to Participate in Upcoming Investor Conferences
Oct 21, 2021 08:00 AM LogicBio Therapeutics Announces Successful Repopulation of Diseased Livers in Mice with Healthy Corrected Hepatocytes in Two New Indications Using GeneRide™ Genome Editing Technology
Oct 18, 2021 08:00 AM LogicBio Therapeutics Announces Early Clinical Trial Results Demonstrating First-Ever In Vivo Genome Editing in Children
Oct 12, 2021 04:05 PM LogicBio Therapeutics to Present New GeneRide™ Data at the European Society of Gene and Cell Therapy Virtual Congress 2021
Sep 24, 2021 04:05 PM LogicBio Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference
Sep 10, 2021 08:00 AM LogicBio Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Aug 9, 2021 08:00 AM LogicBio Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Milestones
Jul 8, 2021 07:00 AM LogicBio Therapeutics to Participate in William Blair Biotech Focus Conference 2021
Jun 2, 2021 07:00 AM LogicBio Therapeutics Announces First Patient Dosed in Groundbreaking Phase 1/2 SUNRISE Clinical Trial for the Treatment of Pediatric Patients Suffering from Methylmalonic Acidemia
Jun 1, 2021 04:05 PM LogicBio Therapeutics to Participate in Upcoming Investor Conferences
May 19, 2021 07:00 AM LogicBio Therapeutics Promotes Daniel Gruskin, MD, to Chief Medical Officer and Announces Additional Leadership Appointments
May 10, 2021 07:30 AM LogicBio Therapeutics Reports First Quarter Year 2021 Financial Results and Provides Business Update
May 10, 2021 07:05 AM LogicBio Therapeutics Strengthens Management Team with Key Appointments
May 4, 2021 08:00 AM LogicBio Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
May 3, 2021 04:30 PM LogicBio Announces Presentation of Retrospective Study of Disease Course in Pediatric Patients with Severe Methylmalonic Acidemia
Apr 27, 2021 07:00 AM LogicBio Therapeutics Announces Research Collaboration with Daiichi Sankyo
Apr 27, 2021 07:00 AM LogicBio Therapeutics Announces Clinical and Corporate Updates
Apr 27, 2021 07:00 AM LogicBio Therapeutics Announces Strategic Collaboration and Option Agreement with CANbridge Pharmaceuticals Leveraging Gene Editing and Gene Delivery Platforms
Mar 30, 2021 04:30 PM LogicBio Therapeutics to Present at 2021 Redburn Gene Therapy Summit
Mar 15, 2021 05:32 PM LogicBio Therapeutics Reports Full Year 2020 Financial Results and Provides Business Update
Feb 26, 2021 02:15 PM LogicBio Therapeutics to Present at Upcoming Investor Conferences
Jan 7, 2021 08:00 AM LogicBio Announces Extension Of Collaboration With Children's Medical Research Institute
Jan 6, 2021 08:00 AM LogicBio Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
Dec 22, 2020 08:00 AM Cecilia Jones Joins LogicBio Therapeutics as Chief Financial Officer
Dec 14, 2020 08:00 AM LogicBio Therapeutics names Daphne Karydas and Jeff Goater to Board of Directors
Oct 9, 2019 04:15 PM Horizon Technology Finance Provides Third Quarter 2019 Portfolio Update

Back to LOGC Stock Lookup